-
1
-
-
0030856731
-
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
-
Presta L.G., Chen H., O'Connor S.J., Chisholm V., Meng Y.G., Krummen L., et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57 (1997) 4593
-
(1997)
Cancer Res
, vol.57
, pp. 4593
-
-
Presta, L.G.1
Chen, H.2
O'Connor, S.J.3
Chisholm, V.4
Meng, Y.G.5
Krummen, L.6
-
2
-
-
27944456516
-
Managing patients treated with bevacizumab combination therapy
-
Gordon M.S., and Cunningham D. Managing patients treated with bevacizumab combination therapy. Oncology 69 Suppl. 3 (2005) 25
-
(2005)
Oncology
, vol.69
, Issue.SUPPL. 3
, pp. 25
-
-
Gordon, M.S.1
Cunningham, D.2
-
3
-
-
27944456879
-
Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer
-
de Gramont A., and Van Cutsem E. Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer. Oncology 69 Suppl. 3 (2005) 46
-
(2005)
Oncology
, vol.69
, Issue.SUPPL. 3
, pp. 46
-
-
de Gramont, A.1
Van Cutsem, E.2
-
4
-
-
34247592770
-
-
FDA approves bevacizumab (Avastin) as a first-line treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer in combination with platinum-based chemotherapy. Available at http://www.fda.gov/cder/Offices/OODP/whatsnew/bevacizumab200610.htm. Accessed December 12, 2006.
-
-
-
-
5
-
-
34247583740
-
-
National Cancer Institute. Bevacizumab Combined With Chemotherapy Prolongs Survival for Some Patients with Advanced Lung Cancer, March 14, 2005. Available at http://www.nci.nih.gov/newscenter/pressreleases/AvastinLung. Accessed December 12, 2006.
-
-
-
-
6
-
-
34247607572
-
Agents hold hope in advanced lung cancer
-
Harding S.M. (Ed), American College of Chest Physicians, New York
-
Macneil J.S. Agents hold hope in advanced lung cancer. In: Harding S.M. (Ed). Chest physician. The official news publication of the American College of Chest Physicians, vol. 1, no. 9 (2006), American College of Chest Physicians, New York 6
-
(2006)
Chest physician. The official news publication of the American College of Chest Physicians, vol. 1, no. 9
, pp. 6
-
-
Macneil, J.S.1
-
7
-
-
2942526896
-
Non-small cell lung cancer and antiangiogenic therapy: what can be expected of bevacizumab?
-
Herbst R.S., and Sandler A.B. Non-small cell lung cancer and antiangiogenic therapy: what can be expected of bevacizumab?. Oncologist 9 Suppl. 1 (2004) 19
-
(2004)
Oncologist
, vol.9
, Issue.SUPPL. 1
, pp. 19
-
-
Herbst, R.S.1
Sandler, A.B.2
-
8
-
-
3042643346
-
Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies
-
Zondor S.D., and Medina P.J. Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies. Ann Pharmacother 38 (2004) 1258
-
(2004)
Ann Pharmacother
, vol.38
, pp. 1258
-
-
Zondor, S.D.1
Medina, P.J.2
-
9
-
-
0037967272
-
Tumorigenesis and the angiogenic switch
-
Bergers G., and Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3 (2003) 401
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 401
-
-
Bergers, G.1
Benjamin, L.E.2
-
10
-
-
21844465659
-
Vascular endothelial growth factor co-ordinates proper development of lung epithelium and vasculature
-
Zhao L., Wang K., Ferrara N., and Vu T.H. Vascular endothelial growth factor co-ordinates proper development of lung epithelium and vasculature. Mech Dev 122 (2005) 877
-
(2005)
Mech Dev
, vol.122
, pp. 877
-
-
Zhao, L.1
Wang, K.2
Ferrara, N.3
Vu, T.H.4
-
11
-
-
0142121282
-
Bevacizumab, bleeding, thrombosis, and warfarin
-
author reply 3543
-
Kilickap S., Abali H., and Celik I. Bevacizumab, bleeding, thrombosis, and warfarin. J Clin Oncol 21 (2003) 3542 author reply 3543
-
(2003)
J Clin Oncol
, vol.21
, pp. 3542
-
-
Kilickap, S.1
Abali, H.2
Celik, I.3
-
12
-
-
2942657615
-
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
-
Johnson D.H., Fehrenbacher L., Novotny W.F., Herbst R.S., Nemunaitis J.J., Jablons D.M., et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 22 (2004) 2184
-
(2004)
J Clin Oncol
, vol.22
, pp. 2184
-
-
Johnson, D.H.1
Fehrenbacher, L.2
Novotny, W.F.3
Herbst, R.S.4
Nemunaitis, J.J.5
Jablons, D.M.6
-
13
-
-
33845490014
-
Paclitaxel-Carboplatin alone or with Bevacizumab for non small cell lung cancer
-
Sandler A.B., Gray R., Perry M.C., Brahmer J., Schiller J.H., Dowlati A., et al. Paclitaxel-Carboplatin alone or with Bevacizumab for non small cell lung cancer. N Engl J Med 355 (2006) 2542-2550
-
(2006)
N Engl J Med
, vol.355
, pp. 2542-2550
-
-
Sandler, A.B.1
Gray, R.2
Perry, M.C.3
Brahmer, J.4
Schiller, J.H.5
Dowlati, A.6
-
14
-
-
0034835022
-
Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis
-
Hsiao E.I., Kirsch C.M., Kagawa F.T., Wehner J.H., Jensen W.A., and Baxter R.B. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol 177 (2001) 861
-
(2001)
AJR Am J Roentgenol
, vol.177
, pp. 861
-
-
Hsiao, E.I.1
Kirsch, C.M.2
Kagawa, F.T.3
Wehner, J.H.4
Jensen, W.A.5
Baxter, R.B.6
-
16
-
-
0036197831
-
Therapeutic bronchoscopy in lung cancer. Laser therapy, electrocautery, brachytherapy, stents, and photodynamic therapy
-
Lee P., Kupeli E., and Mehta A.C. Therapeutic bronchoscopy in lung cancer. Laser therapy, electrocautery, brachytherapy, stents, and photodynamic therapy. Clin Chest Med 23 (2002) 241
-
(2002)
Clin Chest Med
, vol.23
, pp. 241
-
-
Lee, P.1
Kupeli, E.2
Mehta, A.C.3
-
17
-
-
0021888335
-
Physics of surgery with lasers
-
Polanyi T.G. Physics of surgery with lasers. Clin Chest Med 6 (1985) 179
-
(1985)
Clin Chest Med
, vol.6
, pp. 179
-
-
Polanyi, T.G.1
|